Recombinant human interleukin-10 (SCH 52000)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant human interleukin-10 (SCH 52000), covering 2008-03-04 to 2008-03-04. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis [Phase 1]